
MRI After LEEP in Low-Risk Cervical Cancer: SHAPE Findings
An exploratory analysis of the SHAPE trial found 64.4% concordance between pelvic MRI after LEEP/cone and final hysterectomy pathology in low-risk cervical cancer, with only 30.5% sensitivity for residual disease. Negative MRI does not exclude residual tumor; margin status and multidisciplinary review remain essential.










